Eur Rev Med Pharmacol Sci 2022; 26 (10): 3406-3406
DOI: 10.26355/eurrev_202205_28830

HOXA13 upregulation in gastric cancer is associated with enhanced cancer cell invasion and epithelial-to-mesenchymal transition

Y.-X. He, X.-H. Song, Z.-Y. Zhao, H. Zhao

Department of Gastroenterology, Qingdao Central Hospital, Shandong, China.

The article “HOXA13 upregulation in gastric cancer is associated with enhanced cancer cell invasion and epithelial-to-mesenchymal transition, by Y.-X. He, X.-H. Song, Z.-Y. Zhao, H. Zhao, published in Eur Rev Med Pharmacol Sci 2017; 21 (2): 258-265–PMID: 28165563” has been retracted by the authors due to controversial issues with author contributions.

The Publisher apologizes for any inconvenience this may cause.

https://www.staging.europeanreview.org/article/12092

Free PDF Download

To cite this article

Y.-X. He, X.-H. Song, Z.-Y. Zhao, H. Zhao
HOXA13 upregulation in gastric cancer is associated with enhanced cancer cell invasion and epithelial-to-mesenchymal transition

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 10
Pages: 3406-3406
DOI: 10.26355/eurrev_202205_28830

Keywords Related articles:

  1. HOXA13 upregulation in gastric cancer is associated with enhanced cancer cell invasion and epithelial-to-mesenchymal transition
  2. Up-regulated ONECUT2 and down-regulated SST promote gastric cell migration, invasion, epithelial-mesenchymal transition and tumor growth in gastric cancer
  3. MiR-30 suppresses lung cancer cell 95D epithelial mesenchymal transition and invasion through targeted regulating Snail
  4. MiR-105 inhibits gastric cancer cells metastasis, epithelial-mesenchymal transition by targeting SOX9
  5. Upregulation of circular SMAD7 inhibits tumorigenesis of gastric cancer by reversing epithelial-to-mesenchymal transition